• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物介导的纳米杂化体制备用于癌细胞的序贯治疗递送。

Drug-mediation formation of nanohybrids for sequential therapeutic delivery in cancer cells.

机构信息

The State Key Laboratory of Bioreactor Engineering and Key Laboratory for Ultrafine Materials of Ministry of Education, Key Laboratory for Ultrafine Materials of Ministry of Education, Engineering Research Centre for Biomedical Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, China.

College of Materials Science and Engineering, Zhejiang University of Technology, 310014, China.

出版信息

Colloids Surf B Biointerfaces. 2018 Mar 1;163:284-290. doi: 10.1016/j.colsurfb.2017.12.046. Epub 2017 Dec 29.

DOI:10.1016/j.colsurfb.2017.12.046
PMID:29324355
Abstract

In order to overcome the multidrug resistance (MDR) of tumor cells, it is very important to develop nanocarriers which can effectively load drugs while releasing them in a sequential way. Herein, nanohybrids with such properties have been fabricated by a first loading of one anticancer drug onto a silicate nanodisk (Laponite (LP), 25 nm in diameter and 0.92 nm in thickness) and a subsequent assembly with a pH sensitive poly(N-vinylpyrrolidone) (PVP) as a protective layer, followed by a loading of with another anticancer drug. The resulting nanohybrids (LDPM) present a high drug encapsulation efficiency and long-term colloidal stability. However, if the two drugs are loaded onto LP before PVP decoration, the formed particles tend to form microsized aggregates with poor colloidal stability. In vitro release study indicates that LDPM can deliver the anticancer drugs in a sequential way, which can be further accelerated under acidic microenvironments mimicking both solid tumor and endo-lysosomal compartments, exerting synergistic anticancer cytotoxicity. The drug-mediated formation of nanocarriers may enlighten a design of novel nanoplatform for co-delivery of therapeutic agents, beyond anticancer drugs, in a combinative way for drug delivery applications.

摘要

为了克服肿瘤细胞的多药耐药性(MDR),开发能够有效负载药物并以顺序方式释放药物的纳米载体非常重要。在此,通过将一种抗癌药物首先负载到硅酸盐纳米盘中(Laponite(LP),直径为 25nm,厚度为 0.92nm),然后与 pH 敏感的聚(N-乙烯基吡咯烷酮)(PVP)作为保护层进行组装,随后再负载另一种抗癌药物,制备了具有这种特性的纳米杂化物(LDPM)。所得纳米杂化物(LDPM)具有高的药物包封效率和长期胶体稳定性。然而,如果在 PVP 修饰之前将两种药物负载到 LP 上,则形成的颗粒容易形成胶体稳定性差的微尺寸聚集体。体外释放研究表明,LDPM 可以以顺序方式释放抗癌药物,在模拟实体瘤和内溶酶体区室的酸性微环境下可以进一步加速释放,从而发挥协同抗癌细胞毒性作用。药物介导的纳米载体的形成可能为联合药物递送应用中除抗癌药物以外的治疗剂的联合共递药新型纳米平台的设计提供启示。

相似文献

1
Drug-mediation formation of nanohybrids for sequential therapeutic delivery in cancer cells.药物介导的纳米杂化体制备用于癌细胞的序贯治疗递送。
Colloids Surf B Biointerfaces. 2018 Mar 1;163:284-290. doi: 10.1016/j.colsurfb.2017.12.046. Epub 2017 Dec 29.
2
Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.两亲性聚合物介导形成具有强大稳定性和pH敏感性的基于锂皂石的纳米杂化物用于抗癌药物递送。
ACS Appl Mater Interfaces. 2014 Oct 8;6(19):16687-95. doi: 10.1021/am5032874. Epub 2014 Sep 15.
3
Direct assembly of anticancer drugs to form Laponite-based nanocomplexes for therapeutic co-delivery.将抗癌药物直接组装成基于 Laponite 的纳米复合物,用于治疗性共递药。
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:1407-1414. doi: 10.1016/j.msec.2019.02.083. Epub 2019 Feb 21.
4
pH-sensitive Laponite(®)/doxorubicin/alginate nanohybrids with improved anticancer efficacy.具有增强的抗癌疗效的 pH 敏感的 Laponite(®)/阿霉素/海藻酸钠纳米杂化材料。
Acta Biomater. 2014 Jan;10(1):300-7. doi: 10.1016/j.actbio.2013.09.013. Epub 2013 Sep 25.
5
In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.用于药物递送的介孔二氧化硅纳米颗粒上阳离子低聚物涂层的原位可生物降解交联
Colloids Surf B Biointerfaces. 2017 May 1;153:272-279. doi: 10.1016/j.colsurfb.2017.02.033. Epub 2017 Feb 27.
6
Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.工程化细胞微环境响应型多肽纳米载体共包载小分子协同组合用于实体瘤的有效化疗。
Acta Biomater. 2017 Jan 15;48:131-143. doi: 10.1016/j.actbio.2016.10.034. Epub 2016 Oct 26.
7
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.两亲性甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒共载多柔比星和紫杉醇增强抗肿瘤疗效。
Biomaterials. 2011 Nov;32(32):8281-90. doi: 10.1016/j.biomaterials.2011.07.032. Epub 2011 Jul 31.
8
Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.透明质酸修饰的氧化石墨烯纳米杂化物作为靶向和 pH 响应型抗癌药物载体。
ACS Appl Mater Interfaces. 2014 Aug 13;6(15):11882-90. doi: 10.1021/am502423r. Epub 2014 Jul 16.
9
Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.具有叶酸介导和 pH 响应靶向特性的多功能超顺磁纳米载体用于抗癌药物递送。
Biomaterials. 2011 Jan;32(1):185-94. doi: 10.1016/j.biomaterials.2010.09.077. Epub 2010 Nov 9.
10
Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.载多柔比星的两亲性多肽纳米粒作为一种有效的癌症治疗药物传递系统。
Acta Biomater. 2013 Dec;9(12):9330-42. doi: 10.1016/j.actbio.2013.08.015. Epub 2013 Aug 17.

引用本文的文献

1
Improving Riparin-A Dissolution through a Laponite Based Nanohybrid.通过基于锂皂石的纳米杂化物改善瑞帕林-A的溶解性能。
Pharmaceutics. 2023 Aug 14;15(8):2136. doi: 10.3390/pharmaceutics15082136.
2
Polymer-Based Hybrid Nanoarchitectures for Cancer Therapy Applications.用于癌症治疗应用的基于聚合物的混合纳米结构
Polymers (Basel). 2022 Jul 26;14(15):3027. doi: 10.3390/polym14153027.
3
Printing bone in a gel: using nanocomposite bioink to print functionalised bone scaffolds.在凝胶中打印骨骼:使用纳米复合生物墨水打印功能化骨支架。
Mater Today Bio. 2019 Sep;4:100028. doi: 10.1016/j.mtbio.2019.100028.